CAR-T cell therapy researchBiomedical Ethics and RegulationMultiple Myeloma Research and Treatments

Cost-Effectiveness of AIDPATH-Generated CAR-T Therapy for Multiple Myeloma from a German Hospital Perspective: an Early Health Technology Assessment study (Preprint)

I. W. A. Boot, Y. de Graaf, Anna Louisa Weltin, H. J. Vrijhoef

2026.1.27JMIR Cancer

DOI: 10.2196/92253

Abstract

Abstract is not available.

Citation format

BOOT, I. W. A., et al. Cost-effectiveness of AIDPATH-Generated CAR-T therapy for multiple myeloma from a german hospital perspective: An early health technology assessment study (preprint). JMIR Cancer, 2026.